Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Morgan · SciRah

Researcher profile · Semantic Scholar

E. Morgan

Share profile

E. Morgan — researcher profile on SciRah

h-index: 13
Works: 27
Citations: 1,030

Most-cited papers

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial
K. Kaye, Tanaya Bhowmick, S. Metallidis, S. Bleasdale +20 more
2018Journal of the American Medical Association (JAMA)289 citations Open access
Semantic Scholar
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients.
J. Elborn, D. Geller, D. Conrad, S. Aaron +9 more
2015Journal of Cystic Fibrosis73 citations Open access
Semantic Scholar
Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects
D. Geller, P. Flume, D. Griffith, E. Morgan +3 more
2011Antimicrobial Agents and Chemotherapy73 citations Open access
Semantic Scholar
T cell receptor peptide vaccination in rheumatoid arthritis : A placebo-controlled trial using a combination of Vβ3, Vβ14, and Vβ17 peptides
L. Moreland, E. Morgan, T. C. Adamson, Z. Fronek +16 more
199873 citations
Semantic Scholar
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.
P. Flume, D. VanDevanter, E. Morgan, M. Dudley +9 more
2016Journal of Cystic Fibrosis70 citations Open access
Semantic Scholar
Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects
D. Griffith, J. Loutit, E. Morgan, Stephanie Durso +1 more
2016Antimicrobial Agents and Chemotherapy66 citations Open access
Semantic Scholar
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide
D. Gold, R. Smith, A. B. Golding, E. Morgan +9 more
199757 citations
Semantic Scholar
Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects
C. Rubino, S. Bhavnani, J. Loutit, E. Morgan +3 more
2018Antimicrobial Agents and Chemotherapy51 citations Open access
Semantic Scholar
TCR Peptide Therapy in Human Autoimmune Diseases
A. Vandenbark, E. Morgan, R. Bartholomew, D. Bourdette +5 more
2001Neurochemical Research51 citations
Semantic Scholar
A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.
H. Offner, A. Zamora, Heather Drought, A. Matejuk +4 more
2002Journal of Neuroimmunology44 citations
Semantic Scholar
V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study.
Larry W. Moreland, Louis W. Heck, W. Koopman, P. Saway +8 more
1996Journal of Rheumatology42 citations
Semantic Scholar
Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis.
E. Morgan, C. Nardo, Jocelyn P. Diveley, Joel Kunin +3 more
2001Journal of Neuroscience Research23 citations
Semantic Scholar
401A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the Beta-lactamase inhibitor RPX7009 Alone, Meropenem Alone, and both in Combination (Carbavance) TID for 7 days in Healthy Adult Subjects
David A Griffith, C. Rubino, J. Loutit, E. Morgan +2 more
201413 citations Open access
Semantic Scholar
V beta 17 T-cell receptor peptide vaccine. Results of a phase I dose-finding study in patients with rheumatoid arthritis.
L. Moreland, L. Heck, W. Koopman, P. Saway +6 more
1995Annals of the New York Academy of Sciences13 citations
Semantic Scholar
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides.
L. Moreland, E. Morgan, T. C. Adamson, Z. Fronek +16 more
1998Arthritis & Rheumatism12 citations
Semantic Scholar
216. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Beta-lactamase inhibitor Xeruborbactam Alone and in Combination Meropenem in Healthy Adult Subjects
David A Griffith, J. Roberts, S. Wallis, M. P. Hernández-Mitre +4 more
2022Open Forum Infectious Diseases11 citations Open access
Semantic Scholar
A synthetic androstene analogue inhibits collagen-induced arthritis in the mouse.
H. Offner, A. Zamora, S. Subramanian, M. Polanczyk +4 more
2004Clinical Immunology11 citations
Semantic Scholar
Meropenem-Vaborbactam (M-V) Compared With Piperacillin-Tazobactam (P-T) in the Treatment of Adults With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in a Phase 3 Randomized, Double-Blind, Double-Dummy Trial (TANGO 1)
J. Loutit, Karen Fusaro, Shu Zhang, E. Morgan +4 more
201610 citations Open access
Semantic Scholar
Pharmacokinetics (PK) of aerosol MP-376 (aeroquin; levofloxacin inhalation solution) in CF patients
D. Geller, P. Flume, D. Griffith, E. Morgan +3 more
201010 citations Open access
Semantic Scholar
Results of a Phase II Rheumatoid Arthritis Clinical Trial Using T-Cell Receptor Peptides
S. Brostoff, D. Carlo, J. Diveley, E. Morgan +16 more
19999 citations
Semantic Scholar
218. A Phase 1 Study of the Single-Dose Safety, Tolerability, and Pharmacokinetics of the Beta-lactamase inhibitor Xeruborbactam Administered as the Isobutyryloxymethyl Oral Prodrug to Healthy Adult Subjects
David A Griffith, J. Roberts, S. Wallis, M. P. Hernández-Mitre +3 more
2022Open Forum Infectious Diseases7 citations Open access
Semantic Scholar
217. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Lipopeptide QPX9003 in Healthy Adult Subjects
David A Griffith, Y. Carmeli, Shawnee Gehrke, E. Morgan +2 more
2022Open Forum Infectious Diseases6 citations Open access
Semantic Scholar
Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects
D. Griffith, E. Morgan, M. Dudley, J. Loutit
2021Antimicrobial Agents and Chemotherapy5 citations Open access
Semantic Scholar
A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects
M. P. Hernández-Mitre, S. Wallis, E. Morgan, Michael N. Dudley +3 more
2023Antimicrobial Agents and Chemotherapy4 citations Open access
Semantic Scholar
Vβ17 T‐Cell Receptor Peptide Vaccine
L. Moreland, L. Heck, W. Koopman, P. Saway +10 more
19954 citations
Semantic Scholar
1387. Phase I Study to Evaluate the Safety and Pharmacokinetics (PK) of Single and Multiple Ascending Doses (SAD/MAD) of Intravenous (IV) Minocycline in Healthy Adult Subjects
O. Cornely, D. Arenz, O. Barraud, M. Bayliss +9 more
2018Open Forum Infectious Diseases3 citations Open access
Semantic Scholar
Levofloxacin Inhalation Solution ( APT-1026 ) in Stable Cystic Fibrosis Patients
P. Flume, D. VanDevanter, E. Morgan, M. Dudley +9 more
20171 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Loutit×16
Invite
J. Loutit — researcher profile on SciRah
M. Dudley×14
Invite
M. Dudley — researcher profile on SciRah
D. Griffith×7
Invite
D. Griffith — researcher profile on SciRah
David A Griffith×6
Invite
David A Griffith — researcher profile on SciRah

×6

Invite

T. C. Adamson — researcher profile on SciRah

Invite

Z. Fronek — researcher profile on SciRah

Invite

J. Diveley — researcher profile on SciRah

Invite

P. Flume — researcher profile on SciRah

Invite

L. Moreland — researcher profile on SciRah

Invite

W. Koopman — researcher profile on SciRah

Invite

L. Heck — researcher profile on SciRah

Invite

D. Carlo — researcher profile on SciRah